Front Page   

Shanta Biotech's achievement

HYDERABAD: City-based Shanta Biotechnics, known for its Hepatitis B recombinant vaccine, has become the first Indian bio-pharmaceutical company to attract foreign investment in the sector. French bio-pharma major, Merieux Alliance, has obtained about 60 per cent stake in the company and making it the worldwide centre for prophylactic vaccine activities. Shanta Biotech managing director Varaprasad Reddy will continue in his post in the new entity. He said the deal helped the company move into a higher orbit.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Trying to get nuclear deal done: Bush
Democrats win majority in U.S. Senate
Senate may take up Bill on nuclear deal: Mulford
Bush extends olive branch to Pelosi
Democrats get headstart in race for 2008
Nod for Bill to make judges accountable
Ponting apologises
Tamil Nadu airports on high alert
Chennai police strength to be enhanced
Sri Lanka "regrets" Vaharai incident
Mercury passing
Blindness cure in sight
Another `Delhi bandh' today
Move to hand over 54 hectares to KIOCL may spark controversy
Patnaik launches rural uplift scheme
Biotech SEZ at Genome Valley
Minister suspects move to scuttle talks
Engineering student hangs himself
Boy's death in crossfire to be probed
Shanta Biotech's achievement
U.S. cuts visa fee
Pension increased
Gunboats destroyed

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu